98 related articles for article (PubMed ID: 9776279)
21. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
23. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Lahoutte T; Mertens J; Caveliers V; Franken PR; Everaert H; Bossuyt A
J Nucl Med; 2003 Sep; 44(9):1489-94. PubMed ID: 12960197
[TBL] [Abstract][Full Text] [Related]
24. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.
Kuwert T; Probst-Cousin S; Woesler B; Morgenroth C; Lerch H; Matheja P; Palkovic S; Schäfers M; Wassmann H; Gullotta F; Schober O
J Nucl Med; 1997 Oct; 38(10):1551-5. PubMed ID: 9379191
[TBL] [Abstract][Full Text] [Related]
25. Uptake mechanisms of L-3-[125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1.
Jager PL; de Vries EG; Piers DA; Timmer-Bosscha H
Nucl Med Commun; 2001 Jan; 22(1):87-96. PubMed ID: 11233558
[TBL] [Abstract][Full Text] [Related]
26. Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT.
Biersack HJ; Coenen HH; Stöcklin G; Reichmann K; Bockisch A; Oehr P; Kashab M; Rollmann O
J Nucl Med; 1989 Jan; 30(1):110-2. PubMed ID: 2783455
[TBL] [Abstract][Full Text] [Related]
27. [Uptake of DL-3-123I-iodo-alpha-methyltyrosine in recurrent brain tumors].
Guth-Tougelidis B; Müller S; Mehdorn MM; Knust EJ; Dutschka K; Reiners C
Nuklearmedizin; 1995 Apr; 34(2):71-5. PubMed ID: 7761277
[TBL] [Abstract][Full Text] [Related]
28. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.
Weber WA; Dick S; Reidl G; Dzewas B; Busch R; Feldmann HJ; Molls M; Lumenta CB; Schwaiger M; Grosu AL
J Nucl Med; 2001 Aug; 42(8):1144-50. PubMed ID: 11483672
[TBL] [Abstract][Full Text] [Related]
29. Characterization of 3-[123I]iodo-L-alpha-methyl tyrosine ([123I]IMT) transport into human Ewing's sarcoma cells in vitro.
Franzius C; Kopka K; van Valen F; Eckervogt V; Riemann B; Sciuk J; Schober O
Nucl Med Biol; 2001 Feb; 28(2):123-8. PubMed ID: 11295422
[TBL] [Abstract][Full Text] [Related]
30. Renal accumulation and excretion of radioiodinated 3-iodo-alpha-methyl-L-tyrosine.
Shikano N; Kawai K; Nakajima S; Nishii R; Flores LG; Kubodera A; Kubota N; Ishikawa N; Saji H
Ann Nucl Med; 2004 May; 18(3):263-70. PubMed ID: 15233289
[TBL] [Abstract][Full Text] [Related]
31. Characterization of uptake of 3-[(131)I]iodo-alpha-methyl-L-tyrosine in human monocyte-macrophages.
Prante O; Deichen JT; Hocke C; Kuwert T
Nucl Med Biol; 2004 Apr; 31(3):365-72. PubMed ID: 15028249
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of 3-[125I]iodo-alpha-methyl-L-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells.
Nakajima S; Shikano N; Kotani T; Ogura M; Nishii R; Yoshimoto M; Yamaguchi N; Iwamura Y; Kubota N; Ishikawa N; Kawai K
Nucl Med Biol; 2007 Nov; 34(8):1003-8. PubMed ID: 17998105
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent.
Inoue T; Tomiyoshi K; Higuichi T; Ahmed K; Sarwar M; Aoyagi K; Amano S; Alyafei S; Zhang H; Endo K
J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678
[TBL] [Abstract][Full Text] [Related]
35. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
[TBL] [Abstract][Full Text] [Related]
36. Relevance of image fusion with MRI for the interpretation of I-123 iodo-methyl-tyrosine scans in patients with suspected recurrent or residual brain tumor.
Amthauer H; Wurm R; Kuczer D; Ruf J; Michel R; Eisenacher J; Stockhammer F; Denecke T; Felix R; Plotkin M
Clin Nucl Med; 2006 Apr; 31(4):189-92. PubMed ID: 16550008
[TBL] [Abstract][Full Text] [Related]
37. I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours.
Matheja P; Weckesser M; Rickert Ch; Franzius Ch; Palkovic S; Riemann B; Schober O
Nuklearmedizin; 2002; 41(4):191-6. PubMed ID: 12224403
[TBL] [Abstract][Full Text] [Related]
38. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
[TBL] [Abstract][Full Text] [Related]
39. Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
Hellwig D; Gouverneur E; Schaefer A; Raedle J; Menges M; Kirsch CM; Samnick S
Nuklearmedizin; 2008; 47(5):220-4. PubMed ID: 18852930
[TBL] [Abstract][Full Text] [Related]
40. 3-[(123)I]Iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications.
Langen KJ; Pauleit D; Coenen HH
Nucl Med Biol; 2002 Aug; 29(6):625-31. PubMed ID: 12234586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
